www.law360.com/cases/5c8fe34129ae531332fb966f

Parties, docket activity and news coverage of federal case ROMERO v. BRISTOL- MYERS SQUIBB COMPANY et al, case number 3:19-cv-00504, from Florida ...

www.law360.com/cases/58e6506f2a2edd2f07000001

Parties, docket activity and news coverage of federal case Bristol-Myers Squibb Company et al v. Mylan Pharmaceuticals Inc., case number 1:17-cv-00379, from  ...

dockets.justia.com/docket/florida/flndce/3:2019cv00159/102399

Jan 24, 2019 ... Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability case filed on January 24, 2019 in the Florida Northern District ...

www.patentdocs.org/2019/02/momenta-pharmaceuticals-inc-v-bristol-myers-squibb-co-fed-cir-2019.html

Feb 7, 2019 ... Momenta Pharmaceuticals, Inc. v, Bristol-Myers Squibb Co. ... and covered business method patent review) against a Petitioner (loss of patent ... partes review (IPR) brought by Momenta against all claims of U.S. Patent No.

law.justia.com/cases/federal/appellate-courts/ca6/16-3154/16-3154-2017-10-27.html

Oct 27, 2017 ... Relators, former BMS employees, alleged in a qui tam suit that BMS and Otsuka engaged in a ... Relators allege that, despite those agreements, the companies continued to ... Ibanez v. Bristol-Myers Squibb Co., No. 16-3154 (6th Cir. 2017) ... 16-3154 U.S. ex rel. Ibanez v. Bristol-Myers Squibb, et. al. Page 2 ...

www.fiercebiotech.com/biotech/bristol-myers-squibb-to-pay-more-than-515-million-to-resolve-illegal-drug-marketing-and

Oct 1, 2007 ... Bristol-Myers Squibb Company (BMS) and its wholly owned subsidiary, ... Ven-A- Care of the Florida Keys, et al. v. Apothecon, et al., Civil Action ...

www.bms.com/researchers-and-partners/our-r-and-d-team/research-publications.html

All-Cause, Stroke/Systemic Embolism-, and Major Bleeding-Related Health-Care ..... Outcomes at 7 years post-transplant in black vs nonblack kidney transplant recipients ...... Bethesda (MD): Eli Lilly & Company and the National Center for Advancing ...... in patients with impaired renal function: response to Hellfritzsch et al.